Editorial
Should we expand liver transplant criteria to cirrhotic patients with intrahepatic cholangiocarcinoma?
Abstract
Liver transplantation (LT) for “very early” intrahepatic cholangiocarcinoma (IHCC) in patients with end-stage liver disease (ESLD) has been advocated by the IHCC International Consortium based on a recently published multicenter study (1).